Partnering with Dianosic
Dianosic de-risks your formulation work, preclinical in vivo activities and ensures Clinical Phase 1 readiness, thus creating significant value for your molecule to differentiate it versus generics (Value added Medicines approach), optimize drug-delivery to overcome safety and efficacy challenges and, overall, provide ammunitions in your products LifeCycle Management (LCM).
Our platform is built for pharmaceutical co-development
Unlike incremental improvements to existing delivery routes, our platform structurally resolves the patient adherence challenge: once administered in-office by an ENT physician, this solid dosage form insert autonomously delivers the active pharmaceutical ingredient (API) over periods of 6 to 12 months with no daily requirement from the patient. The bioresorbable nature of the insert ensures excellent nasal retention without compromising patient comfort or quality of life.
This ‘insert and forget’ paradigm represents a compelling Lifecycle Management value proposition for pharmaceutical partners with molecules facing the patent cliff, seeking disruptive modes of administration, or focusing on Value Added Medicines. Our drug-enabling approach offers a significant differentiation for their molecules.
Our collaboration models : flexibility and optionality combined with speed
1. Classic co-development | Your small molecule, our platform
Integrate your API into the DIAXX platform. We work jointly on formulation and preclinical in vivo validation — accelerating time-to-proof-of-concept with a de-risked, proprietary drug-delivery system.
2. Out-licensing | Access our platform via our internal programs
In-license the Dianosic solution across both respiratory (chronic allergic rhinitis, chronic rhinosinusitis) and CNS (schizophrenia) indications.
3. Strategic alliance to break barriers | Build a long-term innovation pipeline together
Beyond small molecules, Dianosic is open to exploring formulation work for other therapeutic modalities on a case-by-case basis.
Non exhaustive list of indications
- Respiratory — Chronic Allergic Rhinitis
- Respiratory — Chronic Rhinosinusitis
- Neuropsychiatric — Schizophrenia, depression, PTSD…
- Neurodegenerative — Alzheimer’s disease, Parkinson’s disease, Lewy Body Dementia (LBD)…
- Neurology — Epilepsy, pain
